Comparative efficacy of atenolol and labetalol in essential hypertension--a double blind cross over trial. 1989

S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan

In a double blind cross-over drug trial, antihypertensive effects (resting and after dynamic exercise) of atenolol and of labetalol were studied in 20 patients of mild to moderate essential hypertension. Both drugs exhibited almost equal antihypertensive response, and were well tolerated. Haemodynamic variables (HR, SBP, DBP and RPP), both at rest and after maximal tread mill exercise, were significantly altered (P less than 0.001) by both drugs. Exercise capacity was observed to be marginally improved by atenolol. Although the antihypertensive effect, when compared between the two drugs, was not statistically significant, individual suitability or comparison revealed a preference for atenolol in 17 patients and for labetalol in 3 patients.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
December 1978, European journal of clinical pharmacology,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
June 1987, The Journal of the Association of Physicians of India,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
January 1989, Drugs under experimental and clinical research,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
February 1998, Journal of human hypertension,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
February 1985, International journal of clinical pharmacology, therapy, and toxicology,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
September 1985, The American journal of cardiology,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
October 1990, Journal of human hypertension,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
January 1988, La Revue de medecine interne,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
January 1987, Journal of cardiovascular pharmacology,
S C Srivastava, and Jagdish, and V K Katyal, and H Singh, and R Mohan
January 1990, European journal of clinical pharmacology,
Copied contents to your clipboard!